Klin Onkol 2015; 28(3): 225-228.
Comments to:
Special Issue – Seminars in Surgical Oncology: Multidisciplinary Advances in Soft Tissue Sarcoma
editoři: Kraybill WG, Pollock RE.
J Surg Oncol 2015; 111(5): 489– 655. doi: 10.1002/ jso.23875. PubMed PMID: 25810082.
Randomized Phase II Trial of Gemcitabine Plus TH- 302 versus Gemcitabine in Patients with Advanced Pancreatic Cancer
Board MJ, Reddy SG, Bahary N et al.
J Clin Oncol 2015; 33(13): 1475– 1481. doi: 10.1200/ JCO.2014.55.7504. PubMed PMID: 25512461.
No Increased Risk of Second Cancer after Radiotherapy in Patients Treated for Rectal for Endometrial Cancer in the Randomized TME, PORTEC- 1, and PORTEC- 2 Trials
Wiltink LM, Nout RA, Fiocco M et al.
J Clin Oncol 2015; 33(15): 1640– 1646. doi: 10.1200/ JCO.2014.58.6693. PMID: 25534376.
Regorafenib Plus Modifi ed FOLFOX6 as First-line Treatment of Metastatic Colorectal Cancer: a Phase II Trial
Argilés G, Saunders MP, Rivera F et al.
Eur J Cancer 2015; 51(8): 942– 949. doi: 10.1016/ j.ejca.2015.02.013. PubMed PMID: 25818084.
Early Tumour Shrinkage as a Prognostic Factor and Surrogate End-point in Colorectal Cancer: a Systematic Review and Pooled- analysis
Petrelli F, Pietrantonio F, Cremolini C et al.
Eur J Cancer 2015; 51(7): 800– 807. doi: 10.1016/ j.ejca.2015.02.011. PubMed PMID: 25794604.
Alopecia as Surrogate Marker for Chemotherapy Response in Patients with Primary Epithelial Ovarian Cancer: a Metaanalysis of Four Prospective Randomised
Phase III Trials with 5,114 Patients
Sehouli J, Fotopoulou CH, Erol E et al.
Eur J Cancer 2015; 51(7): 825– 832. doi: 10.1016/ j.ejca.2015.01.008. PubMed PMID: 25771433.
Non- intercepted Dose Errors in Prescribing Anti-neoplastic Treatment: a Prospective, Comparative Cohort Study
Mattsson OT, Holm B, Michelsen H et al.
Ann Oncol 2015; 26(5): 981– 986. doi: 10.1093/ annonc/ mdv032. PubMed PMID: 25632069.
The Distance between Breast Cancer and the Skin is Associated with Axillary Nodal Metastasis
Eom YH, Kim EJ, Chae BJ et al.
J Surg Oncol 2015; 111(7): 824– 828. doi: 10.1002/ jso.23898. PubMed PMID: 25847102.
The Night Before the First Day of School
Levy A.
J Clin Oncol 2015; 33(13): 1509– 1510. doi: 10.1200/ JCO.2014.60.5790. PubMed PMID: 25823733.
Ramucirumab versus Placebo in Combination with Second-line FOLFIRI in Patients with Metastatic Colorectal Carcinoma that Progressed During or after First-line Therapy with Bevacizumab, Oxaliplatin, and a Fluoropyrimidine (RAISE): a Randomised, Double-blind, Multicentre, Phase 3 Study
Tabernero J, Yoshino T, Cohn AL et al.
Lancet Oncol 2015; 16(5): 499– 508. doi: 10.1016/ S1470- 2045(15)70127- 0. PubMed PMID: 25877855.
Treatment with Two Diff erent Doses of Sonidegib in Patients with Locally Advanced or Metastatic Basal Cell Carcinoma (BOLT): a Multicentre, Randomised, Double-blind Phase 2 Trial
Migden MR, Guminski A, Gutzmer R et al.
Lancet Oncol 2015. doi: 10.1016/ S1470- 2045(15)70100- 2. PubMed PMID: 25981810.
Vismodegib in Patients with Advanced Basal Cell Carcinoma (STEVIE): a Pre-planned Interim Analysis of an International, Open- label Trial
Basset- Seguin N, Hauschild A, Grob JJ et al.
Lancet Oncol 2015. doi: 10.1016/ S1470- 2045(15)70198- 1. PubMed PMID: 25981813.
A Microfl uidic Device for Label-free, Physical Capture of Circulating Tumor Cell Clusters
Sarioglu AF, Aceto N, Kojic N et al.
Nat Methods 2015. Published online 18 May 2015. doi:10.1038/ nmeth.3404. PubMed PMID: 25984697.
Personalizing, not Patronizing: the Case for Patient Autonomy by Unbiased Presentation of Management Options in Stage I Testicular Cancer
Oldenburg J, Aparicio J, Beyer J et al.
Ann Oncol 2015; 26(5): 833– 838. PubMed PMID: 25378299.
